MediPharm Labs Appoints Former President of Janssen Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, to Board of Directors

— MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE:MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, is pleased to announce the appointment of Chris Halyk – former President of Janssen Inc. (Canada), one of the Janssen Pharmaceutical Companies of Johnson & Johnson – to its Board of Directors,Continue reading “MediPharm Labs Appoints Former President of Janssen Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, to Board of Directors”

Aurora Cannabis Announces Retirement of Terry Booth from Board of Directors

– Aurora Cannabis Inc. (the “Company” or “Aurora“) (NYSE: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, today announced that Co-Founder Terry Booth has retired from his role as Director of the Company, effective June 26, 2020. Mr. Booth was the Chief Executive Officer of Aurora from December 2014 through February 2020 and served on Aurora’s Board of Directors since December 2014.Continue reading “Aurora Cannabis Announces Retirement of Terry Booth from Board of Directors”

MedMen Announces Changes to Its Board of Directors and Resolution of MMMG-MC Litigation – Designated News Release

–MedMen Enterprises Inc. (“MedMen” or the “Company”) (CSE: MMEN) (OTCQX: MMNFF) today announced that Adam Bierman, Co-Founder, stepped down as a member of the Company’s Board of Directors. In addition, Andrew Modlin, the Company’s other Co-Founder, stepped down as an observer to the Company’s Board of Directors. Mr. Modlin’s employment agreement with the Company expiredContinue reading “MedMen Announces Changes to Its Board of Directors and Resolution of MMMG-MC Litigation – Designated News Release”

Canopy Rivers Welcomes Canopy Growth CFO Mike Lee to Board of Directors

– Canopy Rivers Inc. (“Canopy Rivers” or the “Company“) (TSX: RIV) (OTC: CNPOF) today welcomed Canopy Growth Corporation (“Canopy Growth“) (TSX: WEED) (NYSE: CGC) Chief Financial Officer Mike Lee to its Board of Directors (the “Board“). Mr. Lee joins a Board that already has executives drawn from multiple industries, a wealth of strategic industry know-how, and significant public companyContinue reading “Canopy Rivers Welcomes Canopy Growth CFO Mike Lee to Board of Directors”

Vireo Health Announces Resignation of Bruce Linton as Board Member

— Vireo Health International, Inc. (“Vireo” or the “Company”) (CNSX: VREO;OTCQX: VREOF), a leading physician-led, science-focused, multi-state cannabis company, today announced Bruce Linton resigned yesterday from the Company’s board of directors. “We wish Bruce well in his future endeavors,” said Kyle Kingsley, M.D., Chief Executive Officer & Founder of Vireo. About Vireo Health International, Inc. Vireo Health International, Inc. isContinue reading “Vireo Health Announces Resignation of Bruce Linton as Board Member”

Cresco Labs Announces the Appointment of National Basketball Players Association Executive Director and Renowned Trial Lawyer Michele Roberts to its Board of Directors

–Cresco Labs (CSE:CL)(OTCQX:CRLBF) (“Cresco” or “the Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced that it has welcomed current Executive Director of the National Basketball Players Association (“NBPA”), Michele Roberts, to its board of directors, effective immediately. A distinguished trial lawyer, celebrated business leader and former member of the adjunctContinue reading “Cresco Labs Announces the Appointment of National Basketball Players Association Executive Director and Renowned Trial Lawyer Michele Roberts to its Board of Directors”